DXB 7.37% 51.0¢ dimerix limited

Ann: Dimerix presentation at Bioshares Biotech Summit, page-53

  1. 1,986 Posts.
    lightbulb Created with Sketch. 435
    Oh MM...

    Give up, move on. You are so boring now that even your banter isn't fun.

    Help me understand why do you care if there is a delay in recruitment or not? Are you planning to buy or you asking ppl. to sell.

    Anyone who has ever invested in Biotech would know that delays to recruitment are always expected, tbh, it would be foolish to not assume that and the market already factors that in. Even trials run by MNC's with unlimited resources are never on time. I financially managed 100+ P1-P3 trials in Australia for one of the big 4 Pharma and hardly ever hit the recruitment timelines (delays can range between few weeks to months) or budgeted spending.

    Biotech investing strategy doesn't change from some delays, its about the fundamentals.

    Now that being said, what else you want us to warn about?

 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
51.0¢
Change
0.035(7.37%)
Mkt cap ! $280.6M
Open High Low Value Volume
47.5¢ 54.0¢ 47.5¢ $3.360M 6.544M

Buyers (Bids)

No. Vol. Price($)
2 25428 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
51.5¢ 15478 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.